Stage III Breast Cancer Not Yet Recruiting Phase 2 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02115152Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast CancerTreatment